| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |